RxDoctor Payments Data

Daniel Grove, MD

Dermatology · Charleston, SCNPI 1962851428

Payments from drug & device makers

$5,165in general payments, 2019–2025

Across 125 payments — averaging $41.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$561
  • LEO Pharma Inc.$460
  • E.r. Squibb & Sons, L.L.C.$435
  • Dermavant Sciences, Inc.$390
  • UCB, Inc.$361
  • Arcutis Biotherapeutics, Inc.$330
  • plus $3K from 20 others
$1,596in research payments, 2019–2025

Across 10 payments — averaging $159.64 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Regeneron$2K

What the payments were for

  • Food & beverage$4,88995%
  • Education$2765%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,165 in reported general payments places this provider in the 55th percentile of 203 dermatology providers in South Carolina.

See all dermatology providers in South Carolina

Medicare billing

Part B allowed, 2024
$2,944
Medicare patients
21
Services billed
49

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other dermatology in Charleston

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →